The finding that only CD8 compartment is associated with a worse disease outcome may be consistent with the concept that CD8 T cells are the key components of tumor immune surveillance, and, thus, the tumor-induced dysfunction may be more evident in the CD8-cell subset than in the CD4-cell compartment [7,13,14]. The gene discussed is CD8A; the disease is neoplasm.